P
Paul S. Donnelly
Researcher at University of Melbourne
Publications - 215
Citations - 7933
Paul S. Donnelly is an academic researcher from University of Melbourne. The author has contributed to research in topics: Copper & Biodistribution. The author has an hindex of 45, co-authored 202 publications receiving 6785 citations. Previous affiliations of Paul S. Donnelly include University of Western Australia & University of Cambridge.
Papers
More filters
Journal ArticleDOI
Copper complexes of a novel non-innocent quadridentate ligand
TL;DR: Quadridentate ligand H(2)L binds Cu(I) to form salt which undergoes aerial oxidation in solution with isolation of the diamagnetic salt [Cu(II)L˙(-)]BF(4) where π-radical anion L˙(-) is the (1e(-), 2H(+)) oxidation product of H( 2)L.
Journal ArticleDOI
Oxorhenium(V) and Oxotechnetium(V) Complexes of N3S Tetradentate Ligands with a Styrylpyridyl Functional Group: Toward Imaging Agents to Assist in the Diagnosis of Alzheimer's Disease.
Benjamin Spyrou,Ingebjørg N Hungnes,Filipa Mota,Jayanta Bordoloi,Philip J. Blower,Jonathan M. White,Michelle T. Ma,Paul S. Donnelly +7 more
TL;DR: In this paper, three tetradentate ligands of pyridyl, amide, amine and thiol donors were prepared, and two rhenium complexes were characterized by X-ray crystallography.
Patent
Novel imaging composition and uses thereof
TL;DR: In this article, the authors discuss the use of hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal center, particularly for the imaging of tumours.
Journal ArticleDOI
CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1 G93A mice with a C57BL/6 background.
Jeremy S. Lum,Mikayla L. Brown,Mikayla L. Brown,Natalie E. Farrawell,Natalie E. Farrawell,Luke McAlary,Luke McAlary,Diane Ly,Diane Ly,Christen G. Chisholm,Christen G. Chisholm,Josh Snow,Kara L. Vine,Kara L. Vine,Tim Karl,Fabian Kreilaus,Lachlan E. McInnes,Sara Nikseresht,Paul S. Donnelly,Peter J. Crouch,Justin J. Yerbury,Justin J. Yerbury +21 more
TL;DR: In this article, the synthetic copper-containing compound, CuATSM, was evaluated in high copy SOD1G93A mice on the congenic C57BL/6 background, treating at 100 mg/kg/day by gavage, starting at 70 days of age.